Korean Multiple Myeloma Working Party

Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment

Sung-Soo Yoon, Y. Do, Je-Jung Lee, 2012, Annals of Hematology.

Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study

Kihyun Kim, S. Kim, Je-Jung Lee, 2014, Annals of Hematology.

Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea—experience from 110 patients

J. H. Lee, V. Voelter, Kihyun Kim, 2013, Annals of Hematology.

Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2010, Annals of Hematology.

A Multicenter Retrospective Analysis of Adverse Events in Korean Patients Using Bortezomib for Multiple Myeloma

Y. Min, Kihyun Kim, Sung-Soo Yoon, 2006, International journal of hematology.